Insider Ledger

MRK insider buying and SEC filings, explained

Merck & Co., Inc. · CIK 310158

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Insider activity in the last 12 months

Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$40.9M
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Aug 13, 2026SaleChirfi Guindo (EVP, Access, Policy & Comms) sold 10,000 shares at $135.00 ($1.4M). Holdings down 21% to 36,613 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 13, 2026
Aug 12, 2026SaleJennifer Zachary (EVP, General Counsel) sold 80,315 shares at about $133.46 ($10.7M). Holdings down 64% to 45,509 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 13, 2026
Aug 10–12, 2026SaleRichard R. DeLuca (EVP&Pres, Merck Animal Heallth) sold 45,320 shares between Aug 10 and Aug 12 at about $131.12 ($5.9M). Holdings down 29% to 110,167 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 12, 2026
Aug 6, 2026SaleRichard R. DeLuca (EVP&Pres, Merck Animal Heallth) sold 6,050 shares at about $130.37 ($789K). Holdings down 4% to 155,487 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 10, 2026
Aug 6, 2026SaleChirfi Guindo (EVP, Access, Policy & Comms) sold 15,000 shares at $131.00 ($2.0M). Holdings down 24% to 46,613 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Aug 7, 2026
Feb 12, 2026SaleChirfi Guindo (Chief Marketing Officer) sold 10,000 shares at about $121.46 ($1.2M). Holdings down 14% to 60,615 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 12, 2026
Feb 10, 2026SaleDean Y Li (President / COO) sold 10,235 shares at about $117.52 ($1.2M). Holdings down 10% to 92,035 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 10, 2026
Feb 9, 2026SaleChirfi Guindo (Chief Marketing Officer) sold 10,000 shares at about $118.41 ($1.2M). Holdings down 12% to 70,615 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 9, 2026
Feb 6, 2026SaleJohannes Jacobus Oosthuizen (President / COO) sold 15,000 shares at about $121.87 ($1.8M). Holdings down 41% to 21,197 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 6, 2026
Feb 6, 2026SaleRichard R. DeLuca (EVP&Pres, Merck Animal Heallth) sold 37,685 shares at about $120.92 ($4.6M). Holdings down 19% to 160,174 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 6, 2026
Feb 5, 2026SaleChirfi Guindo (Chief Marketing Officer) sold 20,000 shares at about $121.88 ($2.4M). Holdings down 20% to 80,615 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 6, 2026
Feb 4, 2026SaleDalton E. Smart III (SVP Fin. - Global Controller) sold 6,400 shares at $119.68 ($766K). Holdings down 44% to 8,205 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 6, 2026
Feb 4, 2026SaleRobert M Davis (CEO and Director) sold 47,434 shares at about $118.04 ($5.6M). Holdings down 10% to 443,602 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Feb 6, 2026
Nov 10, 2025SaleCristal N Downing (Chief Comm. & Public Afrs Ofcr) sold 7,085 shares at $87.00 ($616K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Nov 12, 2025
Nov 3, 2025SaleDavid Michael Williams (EVP,Chief Info&Digital Officer) sold 8,614 shares at about $83.59 ($720K). Holdings down 26% to 24,578 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Nov 4, 2025

75 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow MRK in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app